Toll-like receptor 4 (TLR4) antagonist eritoran tetrasodium attenuates liver ischemia and reperfusion injury through inhibition of high-mobility group box protein B1 (HMGB1) signaling

Molecular medicine (Cambridge, Mass.)

Volumn 20, Issue , 2014, Pages 639-648

  Mcdonald, Kerry Ann ^a   Huang, Hai ^a   Tohme, Samer ^a   Loughran, Patricia ^a   Ferrero, Kimberly ^a   Billiar, Timothy ^a   Tsung, Allan ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISACCHARIDE; ERITORAN; HIGH MOBILITY GROUP B1 PROTEIN; HMGB1 PROTEIN, MOUSE; INTERLEUKIN 6; INTERLEUKIN-6, MOUSE; LIPOPOLYSACCHARIDE; SUGAR PHOSPHATE; TLR4 PROTEIN, MOUSE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CELL CULTURE; CELL LINE; DRUG EFFECTS; LIVER; LIVER CELL; LIVER DISEASES; MALE; METABOLISM; PATHOLOGY; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE; CELLS, CULTURED; DISACCHARIDES; HEPATOCYTES; HMGB1 PROTEIN; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; LIVER; LIVER DISEASES; MALE; MICE, INBRED C57BL; REPERFUSION INJURY; SIGNAL TRANSDUCTION; SUGAR PHOSPHATES; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84965089938     PISSN: None     EISSN: 15283658     Source Type: Journal    
DOI: 10.2119/molmed.2014.00076     Document Type: Article

References (0)